3
1
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T13427 |
(3S,4R)-Tofacitinib
|
Others | Others |
(3S,4R)-Tofacitinib is an less active enantiomer of Tofacitinib. Tofacitinib is a JAK3 inhibitor(IC50 : 1 nM). | |||
T2398 |
Tofacitinib Citrate
CP-690550 citrate,柠檬酸托法替尼,枸橼酸托法替尼,Tasocitinib citrate,Tofacitinib (CP-690550) Citrate |
Apoptosis; Influenza Virus; JAK; Antibacterial; Antifungal | Angiogenesis; Apoptosis; Chromatin/Epigenetic; JAK/STAT signaling; Microbiology/Virology; Stem Cells |
Tofacitinib Citrate (CP-690550 citrate) 是 JAK1/2/3抑制剂,IC50分别为112,20 和 1 nM。它具有抗菌,抗真菌和抗病毒活性。 | |||
T6321 |
Tofacitinib
托法替尼,Tasocitinib,CP-690550 |
ROCK; Apoptosis; JAK; Src | Angiogenesis; Apoptosis; Cell Cycle/Checkpoint; Chromatin/Epigenetic; Cytoskeletal Signaling; JAK/STAT signaling; Stem Cells; Tyrosine Kinase/Adaptors |
Tofacitinib (Tasocitinib) 是口服小分子 Janus 激酶抑制剂,用于治疗中度至重度类风湿性关节炎。 |
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
TMIJ-0137 |
Tofacitinib-d3 Citrate
|
||
Tofacitinib-d3 Citrate 是 Tofacitinib Citrate 的氘代化合物。Tofacitinib Citrate 的 CAS 号为 540737-29-9。Tofacitinib citrate是JAK1/2/3抑制剂,IC50分别为112,20 和 1 nM。它具有抗菌,抗真菌和抗病毒活性。 |